RXi Pharmaceuticals Corporation

257 Simarano Drive Suite 101
Marlborough, Massachusetts 01752
United States View Map >>

P: (508) 767-3861
F: (508) 767-3862
www.rxipharma.com
Description
RXi Pharmaceuticals Corporation (NASDAQ: RXII) is a clinical-stage company developing innovative therapeutics that address significant unmet medical needs. Building on the pioneering discovery of RNAi, the Company's discovery and clinical development programs are based on its proprietary self-delivering RNAi (sd-rxRNA) platform and Samcyprone, a sm... more

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Contact People at this company

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Contact People at this company
Revenue
6000
Employees
30

Products & Services

rnai therapeutics

Industries

Biotechnology, Drug Manufacturing & Research

Similar Companies

Sirna Therapeutics , Inc., Intradigm Corporation, Alnylam Pharmaceuticals , Inc., Applied Biosystems Ltd

Stock Market

NASDAQ: RXII

SIC Codes

2834

NAICS Codes

325412

Recently updated profiles at this company (28 contacts available)

Geert Cauwenbergh
President and Chief Executive Officer
Katherine Holton
Scientist I
Manasa Survi
Regulatory Affairs Associate
Pamela Pavco
Chief Development Officer
James Cardia
Manager, Platform Technology
Lyn Libertine
Vice President Medical Affairs and Safety Assessment
City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory